Dzulkefly Ahmad Appointed as Malaysia's Health Minister Again

News by 2FIRSTS.ai
Dec.13.2023
Dzulkefly Ahmad Appointed as Malaysia's Health Minister Again
Former Malaysian Health Minister Dzulkefly Ahmad has been reappointed in the role, replacing Dr. Zaliha Mustafa in Prime Minister Anwar Ibrahim's cabinet reshuffle.

According to a report by Codeblue on December 12, Malaysia's former Minister of Health, Dzulkefly Ahmad, has been appointed to the position of Minister of Health again in the cabinet reshuffle by Prime Minister Anwar Ibrahim. He replaces Dr. Zaliha Mustafa, who has been appointed as the Deputy Prime Minister (Minister of Federal Territories).

 

Keeferi served as the Minister of Health for nearly two years in the government of Hope Alliance (PH) under the leadership of Mahathir Mohamad.

 

During the press conference, An Hua stated that the Ministry of Health bears significant pressure and requires experienced individuals to take charge. "We believe that Kefiri is capable of fulfilling this responsibility.

 

In the newly restructured Cabinet, Lukanisman Awang Sauni will continue to serve as the Deputy Minister of Health. Kefiri may relinquish his role as the Chairman of the Parliamentary Select Committee on Health (PSSC) due to his new appointment.

 

During her one-year and ten-day tenure as Minister of Health, Zahraha made a significant policy decision to remove liquid and gel nicotine from the list of banned substances under the 1952 drug law. This decision has triggered a joint lawsuit from anti-tobacco groups, who accuse Zahraha of causing harm to public health.

 

The ban on tobacco and e-cigarette generation (GEG) has been lifted from the Public Health Tobacco Control Act, as deemed unconstitutional by Attorney General Ahmad Terrirudin Mohd Salleh.

 

In addition, Kefiri must promptly address the recent new requirements from the Ministry of Health for contract doctors and pharmacists (possibly including dentists), while also facing the issue of low morale in public health services.

 

Disclaimer: 
This article is translated from an original Chinese article available on 2firsts.cn by AI, and has been reviewed and edited by 2FIRSTS's English editorial team. The Chinese original text is the only authoritative source of information. The exclusive copyright and license rights to this article are held by 2FIRSTS Technology Co., Ltd. Any reproduction, reprinting, or redistribution of this article, either in part or in full, requires express written permission from 2FIRSTS and must include clear attribution along with a link to this content. Non-compliance may result in legal action. 2FIRSTS Technology Co., Ltd. reserves the right to pursue legal actions in case of unauthorized use or distribution.